To gain entry into cells, viruses utilize a variety of different cell-surface molecules. Foot-and-mouth disease virus (FMDV) the epitope recognized by the mAb and also regained the ability to be neutralized by the mAb. Moreover, RGD-deleted virions that are noninfectious in animals and other cell types grew to high titers and were able to form plaques on scAb/ ICAMI cells. These studies demonstrate the first production of a totally synthetic cell-surface receptor for a virus. This novel approach will be useful for studying virus reception and for the development of safer vaccines against viral pathogens of animals and humans.
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The first step in viral infection is the binding of virions to cell-surface receptors. Receptors for many different viruses have been identified, and although all of these molecules share a cell-surface topography, there does not appear to be any correlation between the natural function of a cell-surface molecule and the type of virus that uses it as a receptor. In some cases, closely related viruses can use widely divergent cell-surface molecules as cellular receptors. Receptor distribution can also play a role in tissues and/or host species that viruses infect (see ref. 1 
for a review).
Receptor molecules have been identified for several members of the Picornaviridae. The poliovirus receptor (PVR) has been identified as a cellular protein of unknown function (2) , and the receptor for the major group of human rhinoviruses has been identified as intracellular adhesion molecule 1 (ICAM1; refs. [3] [4] [5] . Both of these receptor molecules are members of the immunoglobulin (Ig) superfamily. In contrast, the minor group of human rhinoviruses attach to cells via proteins in the low density lipoprotein receptor family (6) which are not members of the Ig superfamily. The ubiquitous extracellular matrix binding proteins, the integrins, have been identified as receptors for several picornaviruses, including echovirus (7), coxsackievirus type A9 (CA9; ref. 8) , and foot-and-mouth disease virus (FMDV; ref. 9 ). In the case of FMDV, type A12 virus is able to compete with CA9 for the same member of the integrin family (av433; ref. 9) . The finding that this arginine-glycine-aspartic acid (RGD)-specific integrin is a receptor for FMDV is consistent with our work showing that the RGD sequence found in the f3G-f3H loop of VP1 of type A12 virus is absolutely required for infecting cells in culture (10) . Recently, we have made use of the requirement of the RGD for infection to engineer "noninfectious," receptor binding site-deleted virions that can serve as vaccines for FMD (11) .
In addition to gaining access to the cytoplasm of target cells following binding to specific cell-surface proteins, some viruses can infect cells through the Fc receptor if they are complexed to IgG (12) (13) (14) . In the case of dengue virus, this phenomenon, known as antibody-dependent enhancement of infection, has been proposed as the basis for a severe form of disease which accompanies dengue virus infection of hosts who have preexisting low levels of dengue antibodies (15) . In the case of picornaviruses, we have demonstrated that FMDV can also enter cells in this manner (16, 17) , although it is unclear if this route of infection is important in development of either the acute form of disease or the long-term carrier state that has been associated with infection (18) .
In contrast to FMDV, poliovirus cannot productively infect cells by antibody-dependent enhancement of infection (16) , suggesting that the PVR functions both to dock the virus to the cell surface and to induce structural changes to the virion that are necessary for uptake and uncoating. This dual role for some picomavirus receptors in infection is consistent with the finding that soluble forms of PVR or ICAM1 are able to bind to poliovirus or rhinovirus particles, respectively, and induce formation of altered virions that may be related to intermediates in virus uncoating (19, 20) . The critical role of the virus-binding domain of PVR in conformational alteration of the virion is supported by the fact that virus-binding domains of PVR can be transferred to alternative cell-surface molecules such as ICAM1 (21, 22) or CD4 (23), producing chimeric receptor molecules that confer viral susceptibility on cells lacking PVR.
The well-characterized three-dimensional structure of the antigen-binding site of IgG make it particularly amenable to engineering (24) . Recombinant (25) or altered specificities (26 Proc. Natl. Acad. Sci. USA 93 (1996) 10429 recombinant DNA approaches, it has also been possible to generate libraries of IgG-derived molecules that can be used to probe the specificity of antibody/antigen interactions at the structural level (27) . In some of these applications, the antigenbinding domains of the two IgG chains are cloned independently and used in combination to increase the complexity of the libraries (28) , taking advantage of the natural system of generating antibody diversity. It is also possible to engineer single-chain molecules (29, 30) (16) . A plasmid expressing the variable region of the heavy chain and the K chain (VHK) of mAb 2PD11 (pVHK#6) has been described (31) . The eucaryotic expression plasmid, pcDNA3 was obtained from Invitrogen. Plasmid pCB6-ICAM1, containing the human ICAMI cDNA (22) , was provided by E. Wimmer. Wild-type (WT) FMDV type A12 was derived from infectious cDNA pRMC35 (32), the 2PD11 mAb escape mutant (B2PD.3), has been described (33) , and RGDdeleted FMDV type A12 was prepared by transfection of BHK cell cultures with RNA derived from the infectious cDNA plasmid pRM-RGD- (11) . Viral growth curves and plaque assays were performed by standard techniques (32) .
Engineering VHK Molecules for Expression in Eucaryotic Cells. The cDNA encoding a 2PD1 1 VHK was excised from the prokaryotic expression plasmid, PVHK#6 (31) , and ligated to pcDNA3 DNA, behind the cytomegalovirus promoter. To facilitate high-level expression and secretion from eucaryotic cells, 60 bases of untranslated sequence and a 19-codon signal sequence (MELRMCWVLLVSLLKGVLC) from a cDNA (N418) encoding a hamster IgG (A.K., unpublished data) were added to the 5' end of the 2PD11 VHK cDNA. This construction was made using an XhoI site added at the 5th and 6th codons of the framework 1 domain of N418, using the polymerase chain reaction (PCR; ref. 34 ), which permitted inframe fusion to the same restriction endonuclease site in the PVHK#6 cDNA (31) , to produce plasmid PVHK#2 (Fig. 1A) .
Engineering Molecules for Cell-Surface Expression of the VHK. PCR was used to add a linker encoding a GG hinge and an NheI site specifying L and A residues following the 14th codon of the CL domain of the 2PD11 VHK cDNA (at the VL-CL elbow). PCR was also used to add LA codons encoding an NheI site in place of the NA codons found at the N teminus of the mature ICAM molecule (35) , and the two genes were fused together at this site in pcDNA3, producing the recombinant plasmid pscAb/ICAM1#11, shown schematically in Fig. 1B produce clone PVHK#2 (shown schematically in Fig. 1A ).
Clones of CHO cells grown in the presence of G418 from populations of cells transfected with PVHK#2 DNA were tested for their ability to express recombinant antibody as described in Methods. Preliminary immunoprecipitation assays revealed that all the selected clones (n = 3) released proteins of the expected size that reacted with anti-mouse sera, and one (designated 2.9) was used in subsequent studies. The autoradiogram shown in Fig. 2 demonstrates that the culture fluid harvested from radiolabeled CHO 2.9 cells produced a protein of approximately Mr 40,000 that was precipitated with goat anti-mouse IgGs. Furthermore, Fig. 2 shows that the VHK present in the culture fluid harvested from CHO 2.9 cells was able to precipitate radiolabeled FMDV in the presence of anti-mouse IgGs and fixed Staphylococcus aureus bacteria, demonstrating that the substitution of the hamster IgG signal sequence for the pelB leader signal sequence found in PVHK#6 (31) pscAb/ICAM1#1 1-transfected cultures were much lower than those obtained in previous studies of CHO cells expressing the Fc receptor and infected with antibody-complexed virus (16) .
The lower-than-expected titer of virus harvested from these cultures was consistent with the lack of obvious virus-induced cytopathic effect, suggesting that not all of the cells in the culture were expressing functional receptors. This latter possibility was confirmed by immunofluorescent analyses which demonstrated that following infection at a high moi, only a portion of the cells in these transfected cultures contained viral antigen (results not shown). To further evaluate the cells transfected with pscAb/ICAM1#11 DNA, 10 single-cell clones were prepared from these transfected cultures (following two passages in G418; see Methods) and tested for their ability to replicate virus. These experiments identified three clones (designated 11.1, 11.8, and 11.9) that showed significant cytopathic effect when infected with virus, and immunofluorescent staining showed that large percentages of cells in all three cloned cultures were positive for virus antigen 5 h after infection at an moi of greater than 10. One clone, 11.1, was expanded and further tested.
Growth of WT and 2PD11-Resistant Viruses on the Cell Line Expressing the scAb/ICAMI Protein. One-step growth curves confirmed that the CHO 11.1 cell line produced high titers of virus, whereas WT CHO cells were unable to replicate virus (Fig. 3) . The amount of virus recovered from this cell line is similar to that recovered from infected BHK cell cultures (Fig. 3) . Furthermore, WT virus was able to form plaques on the CHO 11.1 cell lines ( Table 2) .
Specificity of this novel receptor for the epitope recognized by 2PD11 was demonstrated by analyzing the 2PD11 mAb escape mutant B2PD.3 (33) . As shown in Table 2, B2PD.3 produced approximately 100,000-fold fewer plaques on the CHO 11.1 cell line relative to WT virus, although both viruses produced comparable plaque titers on susceptible BHK cell cultures. We derived a variant of B2PD.3, designated B2PD.3.9, by two blind passages on CHO 11.1 cells followed by plaque picking and growth on CHO 11.1 cells. B2PD.3.9 efficiently formed plaques on CHO 11.1 cells (Table 2 ) and had regained a partial ability to be neutralized by 2PD11 (the concentration of antibody neutralizing 50% of plaques, PRN5o, was 625 ng/ml for B2PD.3.9 versus > 10,000 ng/ml for B2PD.3, and 20 ng/ml for WT virus). Based on data showing that the 2PD1 1 epitope includes residues found in the G-H loop of VP3 (33), we sequenced this region of B2PD.3.9. These analyses revealed that B2PD.3.9 differed by a single nucleotide from B2PD.3, regenerating a WT Thr codon at position 178 of VP3 of B2PD.3.9, a position that was an Ala codon in all previously characterized 2PD11 mAb escape variants (33) .
Growth of RGD-Deleted Viruses on scAb/ICAM1 Expressing Cells. Since the portion of the virus that binds to the natural cellular receptor is distinct from the site recognized by 2PD11 (31, 33) , we tested the RGD-deleted type A12 virus for ability to infect scAb/ICAMl-expressing cells. Preliminary experiments showed that the RGD-deleted virus obtained from BHK cells transfected with RNA from pRM-RGD-was able to cause cytopathic effect in cell lines 11.1, 11.8, and 11.9. Fig. 4 shows that the RGD-deleted virus was able to form plaques on monolayers of these cells (11.8 and 11.9 not shown). Furthermore, standard methods of virus cultivation yielded high levels of this virus (Fig. 5) , which is noninfectious for animals (11) . The amount of virus recovered from the sucrose gradient shown in Fig. 5 corresponds to a production of over 1.5 ,ug profile of sucrose density gradients prepared from RGD-deleted virus grown in CHO 11.1 cell cultures using standard overnight growth conditions followed by concentration using PEG precipitation prior to centrifugation in sucrose gradients as described (33) . The peak at fraction 6 corresponds to sedimentation of 140S WT virus particles. end (N terminus) of ICAM1 (37) , and (iii) chimeric proteins created by fusing the virus-binding domain of PVR to the N terminus of intact ICAMl are efficient receptors for poliovirus (22) .
Our ability to genetically engineer a scAb/ICAM1 molecule that can function as an FMDV receptor indicates that both the virus-binding site of the scAb and the internalization activity of the ICAM1 molecule were preserved in our engineered receptor. In addition, dramatic differences between the infectivity of WT virus and 2PD1 1 mAb escape mutant, B2PD.3, on the CHO 11.1 cell line, demonstrate the specific interaction between the antigen-binding site expressed in the scAb/ ICAM1 fusion protein and the epitope recognized by the antibody in VP3 of FMDV A12. The rapid derivation of a CHO 11.1-binding variant of B2PD.3 is consistent with extensive antigenic variation and ability to escape from neutralization that has been documented for FMDV both in vitro and in field isolations (38, 39) . The ready isolation of a virus that is capable of binding to this mAb receptor mimics the ability to isolate FMDV variants with enhanced affinity for the natural receptor on cells in culture from animal-derived viruses (40) and is consistent with the ease of isolation of poliovirus variants that are able to replicate on cell lines expressing mutant PVRs (41) .
Our ability to derive a synthetic receptor for FMDV that permits infection following binding in an RGD-independent fashion has provided a method to propagate a previously characterized RGD-deleted virus that has shown usefulness as a safe and effective vaccine candidate (11) . In a preliminary experiment, a bovine inoculated by the intradermal lingual route with 6 ,ugs of the RGD-deleted virus did not show any signs of disease, including either vesicular lesions or fever (E.R. and P.W.M., unpublished data). This mass of virus corresponds to approximately 500 million bovineinfectious doses of the parental virus, derived from pRMC35 (T. S. C. McKenna and P.W.M., unpublished data). This novel approach to the generation of cell lines that can specifically complement receptor mutations introduced into viral genomes may have applications in the derivation of rationally attenuated vaccine candidates for other viruses of humans and domestic animals.
